 | • レポートコード：QFJ1-4489 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、類鼻疽診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（細菌培養試験、ラテックス固定試験、赤血球凝集アッセイ、蛍光抗体法、マトリックス支援レーザー脱離/イオン化、直接蛍光抗体試験、その他）、用途別市場規模（研究所、病院、学術機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・類鼻疽診断の市場動向 ・企業の競争状況、市場シェア ・類鼻疽診断の種類別市場規模と予測2016-2027（細菌培養試験、ラテックス固定試験、赤血球凝集アッセイ、蛍光抗体法、マトリックス支援レーザー脱離/イオン化、直接蛍光抗体試験、その他） ・類鼻疽診断の用途別市場規模と予測2016-2027（研究所、病院、学術機関） ・類鼻疽診断の北米市場規模2016-2027（アメリカ、カナダ） ・類鼻疽診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・類鼻疽診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・類鼻疽診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・類鼻疽診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific, Inc.、Bio-Rad Laboratories, Inc、PerkinElmer Inc.、InBios International, Inc.、Mediven、Cell Signaling Technology, Inc） ・結論 |
Melioidosis, also called as Whitmore’s Disease, is an infectious disease caused by the bacteria Burkholderia pseudomallei. Melioidosis infection usually affects the lungs and is diagnosed by blood, urine, saliva, or skin lesion examination. Melioidosis bacteria are present in polluted water and soil, and they propagate by direct contact with the contaminated source to humans and animals.
Market Analysis and Insights: Global Melioidosis Diagnostic Market
The global Melioidosis Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melioidosis Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melioidosis Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melioidosis Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melioidosis Diagnostic market.
Global Melioidosis Diagnostic Scope and Market Size
Melioidosis Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melioidosis Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Bacterial culture test
Latex fixation test
Hemagglutination assay
Immunofluorescence
Matrix-assisted laser desorption/ionization
Direct fluorescent antibody test
Other Tests
Segment by Application
Research laboratories
Hospitals
Academic institutions
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
PerkinElmer Inc.
InBios International, Inc.
Mediven
Cell Signaling Technology, Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melioidosis Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bacterial culture test
1.2.3 Latex fixation test
1.2.4 Hemagglutination assay
1.2.5 Immunofluorescence
1.2.6 Matrix-assisted laser desorption/ionization
1.2.7 Direct fluorescent antibody test
1.2.8 Other Tests
1.3 Market by Application
1.3.1 Global Melioidosis Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research laboratories
1.3.3 Hospitals
1.3.4 Academic institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Melioidosis Diagnostic Market Perspective (2016-2027)
2.2 Melioidosis Diagnostic Growth Trends by Regions
2.2.1 Melioidosis Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Melioidosis Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Melioidosis Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Melioidosis Diagnostic Industry Dynamic
2.3.1 Melioidosis Diagnostic Market Trends
2.3.2 Melioidosis Diagnostic Market Drivers
2.3.3 Melioidosis Diagnostic Market Challenges
2.3.4 Melioidosis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melioidosis Diagnostic Players by Revenue
3.1.1 Global Top Melioidosis Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Melioidosis Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Melioidosis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Melioidosis Diagnostic Revenue
3.4 Global Melioidosis Diagnostic Market Concentration Ratio
3.4.1 Global Melioidosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melioidosis Diagnostic Revenue in 2020
3.5 Melioidosis Diagnostic Key Players Head office and Area Served
3.6 Key Players Melioidosis Diagnostic Product Solution and Service
3.7 Date of Enter into Melioidosis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melioidosis Diagnostic Breakdown Data by Type
4.1 Global Melioidosis Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Melioidosis Diagnostic Forecasted Market Size by Type (2022-2027)
5 Melioidosis Diagnostic Breakdown Data by Application
5.1 Global Melioidosis Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Melioidosis Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Melioidosis Diagnostic Market Size (2016-2027)
6.2 North America Melioidosis Diagnostic Market Size by Type
6.2.1 North America Melioidosis Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Melioidosis Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Melioidosis Diagnostic Market Size by Type (2016-2027)
6.3 North America Melioidosis Diagnostic Market Size by Application
6.3.1 North America Melioidosis Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Melioidosis Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Melioidosis Diagnostic Market Size by Application (2016-2027)
6.4 North America Melioidosis Diagnostic Market Size by Country
6.4.1 North America Melioidosis Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Melioidosis Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Melioidosis Diagnostic Market Size (2016-2027)
7.2 Europe Melioidosis Diagnostic Market Size by Type
7.2.1 Europe Melioidosis Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Melioidosis Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Melioidosis Diagnostic Market Size by Type (2016-2027)
7.3 Europe Melioidosis Diagnostic Market Size by Application
7.3.1 Europe Melioidosis Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Melioidosis Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Melioidosis Diagnostic Market Size by Application (2016-2027)
7.4 Europe Melioidosis Diagnostic Market Size by Country
7.4.1 Europe Melioidosis Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Melioidosis Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Melioidosis Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Melioidosis Diagnostic Market Size by Type
8.2.1 Asia-Pacific Melioidosis Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Melioidosis Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Melioidosis Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Melioidosis Diagnostic Market Size by Application
8.3.1 Asia-Pacific Melioidosis Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Melioidosis Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Melioidosis Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Melioidosis Diagnostic Market Size by Region
8.4.1 Asia-Pacific Melioidosis Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Melioidosis Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Melioidosis Diagnostic Market Size (2016-2027)
9.2 Latin America Melioidosis Diagnostic Market Size by Type
9.2.1 Latin America Melioidosis Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Melioidosis Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Melioidosis Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Melioidosis Diagnostic Market Size by Application
9.3.1 Latin America Melioidosis Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Melioidosis Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Melioidosis Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Melioidosis Diagnostic Market Size by Country
9.4.1 Latin America Melioidosis Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Melioidosis Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melioidosis Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Melioidosis Diagnostic Market Size by Type
10.2.1 Middle East & Africa Melioidosis Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Melioidosis Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Melioidosis Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Melioidosis Diagnostic Market Size by Application
10.3.1 Middle East & Africa Melioidosis Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Melioidosis Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Melioidosis Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Melioidosis Diagnostic Market Size by Country
10.4.1 Middle East & Africa Melioidosis Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Melioidosis Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Melioidosis Diagnostic Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Melioidosis Diagnostic Business (2016-2021)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc
11.2.1 Bio-Rad Laboratories, Inc Company Details
11.2.2 Bio-Rad Laboratories, Inc Business Overview
11.2.3 Bio-Rad Laboratories, Inc Melioidosis Diagnostic Introduction
11.2.4 Bio-Rad Laboratories, Inc Revenue in Melioidosis Diagnostic Business (2016-2021)
11.2.5 Bio-Rad Laboratories, Inc Recent Development
11.3 PerkinElmer Inc.
11.3.1 PerkinElmer Inc. Company Details
11.3.2 PerkinElmer Inc. Business Overview
11.3.3 PerkinElmer Inc. Melioidosis Diagnostic Introduction
11.3.4 PerkinElmer Inc. Revenue in Melioidosis Diagnostic Business (2016-2021)
11.3.5 PerkinElmer Inc. Recent Development
11.4 InBios International, Inc.
11.4.1 InBios International, Inc. Company Details
11.4.2 InBios International, Inc. Business Overview
11.4.3 InBios International, Inc. Melioidosis Diagnostic Introduction
11.4.4 InBios International, Inc. Revenue in Melioidosis Diagnostic Business (2016-2021)
11.4.5 InBios International, Inc. Recent Development
11.5 Mediven
11.5.1 Mediven Company Details
11.5.2 Mediven Business Overview
11.5.3 Mediven Melioidosis Diagnostic Introduction
11.5.4 Mediven Revenue in Melioidosis Diagnostic Business (2016-2021)
11.5.5 Mediven Recent Development
11.6 Cell Signaling Technology, Inc
11.6.1 Cell Signaling Technology, Inc Company Details
11.6.2 Cell Signaling Technology, Inc Business Overview
11.6.3 Cell Signaling Technology, Inc Melioidosis Diagnostic Introduction
11.6.4 Cell Signaling Technology, Inc Revenue in Melioidosis Diagnostic Business (2016-2021)
11.6.5 Cell Signaling Technology, Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Melioidosis Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bacterial culture test
Table 3. Key Players of Latex fixation test
Table 4. Key Players of Hemagglutination assay
Table 5. Key Players of Immunofluorescence
Table 6. Key Players of Matrix-assisted laser desorption/ionization
Table 7. Key Players of Direct fluorescent antibody test
Table 8. Key Players of Other Tests
Table 9. Global Melioidosis Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Melioidosis Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Melioidosis Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Melioidosis Diagnostic Market Share by Regions (2016-2021)
Table 13. Global Melioidosis Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Melioidosis Diagnostic Market Share by Regions (2022-2027)
Table 15. Melioidosis Diagnostic Market Trends
Table 16. Melioidosis Diagnostic Market Drivers
Table 17. Melioidosis Diagnostic Market Challenges
Table 18. Melioidosis Diagnostic Market Restraints
Table 19. Global Melioidosis Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Melioidosis Diagnostic Market Share by Players (2016-2021)
Table 21. Global Top Melioidosis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melioidosis Diagnostic as of 2020)
Table 22. Ranking of Global Top Melioidosis Diagnostic Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Melioidosis Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Melioidosis Diagnostic Product Solution and Service
Table 26. Date of Enter into Melioidosis Diagnostic Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Melioidosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Melioidosis Diagnostic Revenue Market Share by Type (2016-2021)
Table 30. Global Melioidosis Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Melioidosis Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Melioidosis Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Melioidosis Diagnostic Revenue Market Share by Application (2016-2021)
Table 34. Global Melioidosis Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Melioidosis Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Melioidosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Melioidosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Melioidosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Melioidosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Melioidosis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Melioidosis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Melioidosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Melioidosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Melioidosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Melioidosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Melioidosis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Melioidosis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Melioidosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Melioidosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Melioidosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Melioidosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Melioidosis Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Melioidosis Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Melioidosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Melioidosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Melioidosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Melioidosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Melioidosis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Melioidosis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Melioidosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Melioidosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Melioidosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Melioidosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Melioidosis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Melioidosis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 66. Thermo Fisher Scientific, Inc. Company Details
Table 67. Thermo Fisher Scientific, Inc. Business Overview
Table 68. Thermo Fisher Scientific, Inc. Melioidosis Diagnostic Product
Table 69. Thermo Fisher Scientific, Inc. Revenue in Melioidosis Diagnostic Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific, Inc. Recent Development
Table 71. Bio-Rad Laboratories, Inc Company Details
Table 72. Bio-Rad Laboratories, Inc Business Overview
Table 73. Bio-Rad Laboratories, Inc Melioidosis Diagnostic Product
Table 74. Bio-Rad Laboratories, Inc Revenue in Melioidosis Diagnostic Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Laboratories, Inc Recent Development
Table 76. PerkinElmer Inc. Company Details
Table 77. PerkinElmer Inc. Business Overview
Table 78. PerkinElmer Inc. Melioidosis Diagnostic Product
Table 79. PerkinElmer Inc. Revenue in Melioidosis Diagnostic Business (2016-2021) & (US$ Million)
Table 80. PerkinElmer Inc. Recent Development
Table 81. InBios International, Inc. Company Details
Table 82. InBios International, Inc. Business Overview
Table 83. InBios International, Inc. Melioidosis Diagnostic Product
Table 84. InBios International, Inc. Revenue in Melioidosis Diagnostic Business (2016-2021) & (US$ Million)
Table 85. InBios International, Inc. Recent Development
Table 86. Mediven Company Details
Table 87. Mediven Business Overview
Table 88. Mediven Melioidosis Diagnostic Product
Table 89. Mediven Revenue in Melioidosis Diagnostic Business (2016-2021) & (US$ Million)
Table 90. Mediven Recent Development
Table 91. Cell Signaling Technology, Inc Company Details
Table 92. Cell Signaling Technology, Inc Business Overview
Table 93. Cell Signaling Technology, Inc Melioidosis Diagnostic Product
Table 94. Cell Signaling Technology, Inc Revenue in Melioidosis Diagnostic Business (2016-2021) & (US$ Million)
Table 95. Cell Signaling Technology, Inc Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melioidosis Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Bacterial culture test Features
Figure 3. Latex fixation test Features
Figure 4. Hemagglutination assay Features
Figure 5. Immunofluorescence Features
Figure 6. Matrix-assisted laser desorption/ionization Features
Figure 7. Direct fluorescent antibody test Features
Figure 8. Other Tests Features
Figure 9. Global Melioidosis Diagnostic Market Share by Application: 2020 VS 2027
Figure 10. Research laboratories Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Academic institutions Case Studies
Figure 13. Melioidosis Diagnostic Report Years Considered
Figure 14. Global Melioidosis Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Melioidosis Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Melioidosis Diagnostic Market Share by Regions: 2020 VS 2027
Figure 17. Global Melioidosis Diagnostic Market Share by Regions (2022-2027)
Figure 18. Global Melioidosis Diagnostic Market Share by Players in 2020
Figure 19. Global Top Melioidosis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melioidosis Diagnostic as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Melioidosis Diagnostic Revenue in 2020
Figure 21. Global Melioidosis Diagnostic Revenue Market Share by Type (2016-2021)
Figure 22. Global Melioidosis Diagnostic Revenue Market Share by Type (2022-2027)
Figure 23. North America Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Melioidosis Diagnostic Market Share by Type (2016-2027)
Figure 25. North America Melioidosis Diagnostic Market Share by Application (2016-2027)
Figure 26. North America Melioidosis Diagnostic Market Share by Country (2016-2027)
Figure 27. United States Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Melioidosis Diagnostic Market Share by Type (2016-2027)
Figure 31. Europe Melioidosis Diagnostic Market Share by Application (2016-2027)
Figure 32. Europe Melioidosis Diagnostic Market Share by Country (2016-2027)
Figure 33. Germany Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Melioidosis Diagnostic Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Melioidosis Diagnostic Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Melioidosis Diagnostic Market Share by Region (2016-2027)
Figure 43. China Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Melioidosis Diagnostic Market Share by Type (2016-2027)
Figure 51. Latin America Melioidosis Diagnostic Market Share by Application (2016-2027)
Figure 52. Latin America Melioidosis Diagnostic Market Share by Country (2016-2027)
Figure 53. Mexico Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Melioidosis Diagnostic Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Melioidosis Diagnostic Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Melioidosis Diagnostic Market Share by Country (2016-2027)
Figure 59. Turkey Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Melioidosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Melioidosis Diagnostic Business (2016-2021)
Figure 63. Bio-Rad Laboratories, Inc Revenue Growth Rate in Melioidosis Diagnostic Business (2016-2021)
Figure 64. PerkinElmer Inc. Revenue Growth Rate in Melioidosis Diagnostic Business (2016-2021)
Figure 65. InBios International, Inc. Revenue Growth Rate in Melioidosis Diagnostic Business (2016-2021)
Figure 66. Mediven Revenue Growth Rate in Melioidosis Diagnostic Business (2016-2021)
Figure 67. Cell Signaling Technology, Inc Revenue Growth Rate in Melioidosis Diagnostic Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の抗核抗体検査市場規模・現状・予測（2021年-2027年） Antinuclear antibodies (ANA) are a group of autoantibodies produced by a person's immune system when it fails to adequately distinguish between "self" and "nonself." The ANA test detects these autoantibodies in the blood. Market Analysis and Insights: Global Anti-Nuclear Antibody Test Market The glo…- 世界の体外診断 (IVD) 検査市場規模・現状・予測（2021年-2027年） In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home. Market Analysis and Insights: Global In Vitro Diagnostic (IVD) Test Market The global In Vitro…
- 世界のNGSベース監視＆診断検査市場規模・現状・予測（2021年-2027年） NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an ent…
- 世界の迅速血漿レアギン検査市場規模・現状・予測（2021年-2027年） Rapid plasma reagin test is a serological test used to screen you for syphilis, a sexually transmitted infection caused by spirochete bacterium treponema pallidum. Market Analysis and Insights: Global Rapid Plasma Reagin Test Market The global Rapid Plasma Reagin Test market size is projected to re…
- 世界のミオグロビン検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Myoglobin Test Market The global Myoglobin Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…